Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In this talk, I will briefly overview key genomic findings in relation to schizophrenia, before illustrating the application of integrated neuroscience approaches to understanding the functional impacts of risk variants. I will give examples from both common and rare variants, and will emphasise the potential impacts in terms of biomarker discovery and therapeutic innovation. 

 

This seminar is hosted in the Seminar Room and online: